The reduced form is higher in patients with early AMD and protects ARPE19 cells from oxidative damage, whereas the oxidized form is higher in patients with advanced AMD and can effectively mediate FI to accelerate C3 cleavage [103]. Here, C3 is linked to age-related macular degeneration.